Elise Aasebø's picture

Elise Aasebø

Postdoctoral fellow
  • E-mailElise.Aasebo@uib.no
  • Visitor Address
    Jonas Lies vei 91
  • Postal Address
    Postboks 7804
    5020 Bergen

Uses mass spectrometry-based quantitative proteomics to analyze the proteome in acute myeloid leukemia (AML) patient cells, aiming to unravel more of the complex biological processes behind AML and to find prognostic biomarkers which can guide therapeutic decisions.

Other research interests are cell-cell communication in the AML microenviroment and proteomic method optimization.

Academic article
  • Forthun, Rakel Brendsdal; Aasebø, Elise; Rasinger, Josef Daiel; Bedringaas, Siv Lise; Berven, Frode; Selheim, Frode; Bruserud, Øystein; Gjertsen, Bjørn Tore. 2017. Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia. Journal of Proteomics. 32-41.
  • Hernandez Sanchez, Luis Francisco; Aasebø, Elise; Selheim, Frode; Berven, Frode; Ræder, Helge; Barsnes, Harald; Vaudel, Marc. 2016. Systemic Analysis of Regulated Functional Networks. Methods in molecular biology. 287-310.
  • Hernandez-Valladares, Maria; Aasebø, Elise; Mjaavatten, Olav; Vaudel, Marc; Bruserud, Øystein; Berven, Frode; Selheim, Frode. 2016. Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients. Biological Procedures Online. 1-10.
  • Opsahl, Jill Anette; Vaudel, Marc; Guldbrandsen, Astrid; Aasebø, Elise; Van Pesch, Vincent; Franciotta, Diego; Myhr, Kjell-Morten; Barsnes, Harald; Berle, Magnus Foldal; Torkildsen, Øivind; Kroksveen, Ann Cathrine; Berven, Frode. 2016. Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics. 1154-1165.
  • Aasebø, Elise; Forthun, Rakel Brendsdal; Berven, Frode; Selheim, Frode; Hernandez-Valladares, Maria. 2016. Global cell proteome profiling, phospho-signaling and quantitative proteomics for identification of new biomarkers in acute myeloid leukemia patients. Current Pharmaceutical Biotechnology. 52-70.
  • Aasebø, Elise; Mjaavatten, Olav; Vaudel, Marc; Farag, Yehia Mohamed Mokhtar; Selheim, Frode; Berven, Frode; Bruserud, Øystein; Hernandez-Valladares, Maria. 2016. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows. Journal of Proteomics. 214-225.
  • Kroksveen, Ann Cathrine; Jaffe, Jacob D.; Aasebø, Elise; Barsnes, Harald; Bjørlykke, Yngvild; Franciotta, Diego; Keshishian, Hasmik; Myhr, Kjell-Morten; Opsahl, Jill Anette; van Pesch, Vincent; Teunissen, Charlotte E.; Torkildsen, Øivind; Ulvik, Rune Johan; Vethne, Heidrun; Carr, Steven A.; Berven, Frode. 2015. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 3361-3369.
Academic literature review
  • Selheim, Frode; Aasebø, Elise; Ribas, Catalina; Aragay, Anna M. 2019. An overview on G protein-coupled receptor-induced signal transduction in acute myeloid leukemia. 5293-5316.
  • Aasebø, Elise; Bartaula-Brevik, Sushma; Hernandez-Valladares, Maria; Bruserud, Øystein. 2018. Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia. 13-24.
  • Bruserud, Øystein; Aasebø, Elise; Hernandez-Valladares, Maria; Tsykunova, Galina; Reikvam, Håkon. 2017. Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies. 1053-1065.

More information in national current research information system (CRIStin)

Acute myeloid leukemia research

Research groups